Deal Tracker · Therapeutic areas
Metabolic / Diabetes deals
18 Metabolic / Diabetes deals tracked by EPT across MENA, GCC, Southeast Asia & Africa — licensing, manufacturing & partnerships. Most active: Adalvo, Eva Pharma, Julphar & Novo Nordisk. Latest: Adalvo → SinoPep (Supply / Manufacturing, 27 Oct 2026).
- Adalvo → SinoPepSupply / Manufacturing · Global (LMICs) · Undisclosed · 27 Oct 2026
- Eva Pharma → United PharmaciesDistribution · GCC · Undisclosed · 26 Oct 2026
- Yichang HEC Changjiang Pharmaceutical → Pharmaniaga LifeScienceTechnology transfer / Localization · Southeast Asia · 22 Oct 2026
- Eli Lilly → Mubadala BioSupply / Manufacturing · GCC · Undisclosed · 20 Oct 2026
- Philex Pharmaceuticals → BiocareTechnology transfer / Localization · Africa · 11 Oct 2026
- OneSource Specialty Pharma → Avalon PharmaLicensing · MENA · Undisclosed · 8 Oct 2026
- Dar Al Dawa → MicroSynergy PharmaSupply / Manufacturing · GCC · Undisclosed · 30 Sept 2026
- Eva Pharma → CCL PharmaceuticalsPartnership / Collaboration · Southeast Asia · Undisclosed · 17 Sept 2026
- AstraZeneca → KAIMRCPartnership / Collaboration · GCC · 29 Aug 2026
- Adalvo → Doctors PharmaceuticalLicensing · MENA · Undisclosed · 1 Jul 2026
- Novo Nordisk Algérie → Groupe SaidalTechnology transfer / Localization · MENA · Undisclosed · 30 Jun 2026
- Daewoong Pharmaceutical → Arcera Life SciencesLicensing · MENA · $94m · 29 Jun 2026
- Novo Nordisk → Emirates Drug EstablishmentPartnership / Collaboration · GCC · Undisclosed · 8 Jun 2026
- Hybio Pharmaceutical → MCG PharmaLicensing · Türkiye · Undisclosed · 10 Apr 2026
- Novo Nordisk → LiferaSupply / Manufacturing · GCC · 24 Apr 2025
- Biocon → Tabuk PharmaceuticalsLicensing · MENA · Undisclosed · 9 Feb 2024
- Sunshine Lake Pharma → JulpharLicensing · MENA · Undisclosed · 18 May 2023
- Huadong Medicine → JulpharPartnership / Collaboration · MENA · Undisclosed · 25 Jun 2022
Browse deals
By region
MENA (53) · GCC (48) · Africa (14) · CIS & Central Asia (10) · Southeast Asia (8) · Global (LMICs) (5) · Türkiye (4) · Global ex-US (1)
By deal type
Licensing (38) · Distribution (25) · Technology transfer / Localization (23) · Partnership / Collaboration (22) · M&A / Acquisition (16) · Equity / Investment (7) · Joint venture (5) · Supply / Manufacturing (5)
By company
ADCAN Pharma (11) · Mubadala Bio (8) · Hikma Pharmaceuticals (6) · Jamjoom Pharma (6) · Bio-Thera Solutions (5) · Avalon Pharma (4) · SPIMACO (4) · Groupe Saidal (4) · Department of Health – Abu Dhabi (3) · Roche (3) · Sanofi (3) · Taiba Healthcare (3) · Tabuk Pharmaceuticals (3) · Dar Al Dawa (3) · Kazakhstan Ministry of Health (3) · Galenicum (2) · DKSH (2) · Laprophan (2) · Adalvo (2) · Eva Pharma (2) · Rameda (2) · Menarini (2) · AstraZeneca (2) · MS Pharma (2) · LifePharma (2) · JCR Pharmaceuticals (2) · Gen İlaç (2) · Philex Pharmaceuticals (2) · Lotus Pharmaceutical (2) · Elpen (2) · Dhofar Pharmaceutical Industries (2) · CCL Pharmaceuticals (2) · Abdi İbrahim (2) · Nordic Pharma (2) · SaudiVax (2) · Novo Nordisk (2) · VACSERA (2) · Lifera (2) · Julphar (2)
By therapeutic area
Multi-therapy (34) · Oncology (19) · Cardiovascular (13) · Vaccines (11) · Immunology / Inflammation (8) · Ophthalmology (4) · Rare / Orphan (4) · CNS / Neurology (3) · Consumer health (3) · Infectious Disease (3) · Respiratory (2) · Women's Health (2)